Quick Exit

AstraZeneca's Briggs Morrison, the executive vice president for R&D there, has abruptly left the company, Pharmalot's Ed Silverman reports.

Morrison had been with the company since 2012, and was brought in by CEO Pascal Soriot to "jumpstart the pipeline," Silverman says.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.